Akebia Therapeutics | AKBA - 营业费用



金融业
股票价格
USD
资产
USD 376.57M
现金及等价物
USD 184.84M
销售成本
USD 10.34M
流动资产
USD 252.96M
流动负债
USD 162.94M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 32.61M
销售毛利
USD 47.28M
债务利息支出
4.83M
贷款资金
USD 48.25M
市值
USD 316M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 15.61M
贸易债权人
USD 21.19M
应收帐款人
USD 47.03M


营业费用 更改 日
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alnylam Pharmaceuticals USD 898.54M 66.78M 2026-03
Amgen USD 4.78B 1.12B 2026-03
Ardelyx USD 120.12M 14.46M 2025-12
Astellas Pharma JPY 489.36B 52.69B 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Bayer EUR 10.33B 126M 2025-12
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 17.44B 1.53B 2026-03
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.78B 242M 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pharma Mar EUR 42.28M 4.59M 2026-03
Prothena USD 27.23M 14.95M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03